Re-VOLVE: Phase II clinical trial in women with ovarian cancer progressing post-PARP inhibitor with treatment adapted to real-time assessment of evolving genomic resistance. Circulating tumor DNA ...
Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia A total of 1,560 ...
Intraperitoneal chemotherapy is a treatment for cancers in the abdomen or belly area. This treatment delivers anti-cancer drugs directly into the peritoneal cavity, the area in the belly that contains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results